GoldHaven Resources Confirms Up to 15.85% Copper Mineralization at Three Guardsmen Project
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 09 2025
0mins
Should l Buy CTGO?
Source: Newsfilter
- Copper Discovery: GoldHaven confirms copper mineralization up to 15.85% at its Three Guardsmen Project, indicating significant strength in the mineralized system that could redefine the company's market position.
- Resource Expansion: The company has acquired 811.17 hectares of strategic claims at its Magno Project in the Cassiar region and completed a 354-sample exploration program, confirming mineralization comparable to Coeur Mining's Silvertip deposit, thereby enhancing its resource base.
- Drilling Program: GoldHaven has expanded its diamond drilling program at the Copeçal Gold Project to nine holes, completing 889.55 meters of drilling that confirms subsurface gold mineralization connected to surface anomalies, showcasing the project's potential.
- Diversified Portfolio: GoldHaven commands an exploration portfolio spanning 123,900 hectares, with high-grade copper discoveries and active drilling momentum, providing investors with substantial scale and discovery momentum.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CTGO?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CTGO
Wall Street analysts forecast CTGO stock price to rise
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 30.070
Low
35.00
Averages
35.00
High
35.00
Current: 30.070
Low
35.00
Averages
35.00
High
35.00
About CTGO
Contango ORE, Inc. is engaged in the exploration of gold and associated minerals in Alaska. The Company holds a 30% interest in the Peak Gold JV, which leases approximately 675,000 acres of land for exploration and development on the Manh Choh project, with the remaining 70% owned by KG Mining (Alaska), Inc., an indirect subsidiary of Kinross Gold Corporation, operator of the Peak Gold JV. It also has a lease on the Johnson Tract project from the underlying owner, CIRI Native Corporation, a lease on Lucky Shot project from the underlying owner, Alaska Hardrock Inc. and through its subsidiary has 100% ownership of approximately 8,600 acres of peripheral State of Alaska mining claims. It also owns a 100% interest in an additional approximately 145,000 acres of State of Alaska mining claims through its wholly owned subsidiary, which gives the Company an exclusive right to explore and develop minerals on these lands. The Company also owns Golden Zone and Amanita NE gold properties.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Contango Ore Named Among Top Gold Stocks by Analysts
- Significant Project Progress: Contango Ore has made substantial advancements in its underground drilling program at the Lucky Shot project in Alaska, with initial results confirming the continuity of the historically mined Lucky Shot vein, which is expected to enhance understanding of other veins and strengthen the company's competitive position in the gold market.
- Successful Financing: On February 12, the company completed an underwritten offering of 1.67 million shares, raising $50 million in gross proceeds, with plans to allocate approximately $45 million for buying back gold hedge contracts and $700,000 for purchasing gold put contracts, thereby enhancing financial flexibility.
- Future Planning: Contango Ore aims to deliver a feasibility study for the Lucky Shot project in H1 2027, further validating the geological model and advancing the commercialization process, demonstrating the company's confidence in future development.
- Strategic Partnerships: Contango Ore holds a 30% interest in the Peak Gold Joint Venture, which is expected to commence production in 2024, indicating the company's potential and strategic positioning in Alaska's mining development.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating RAPT Therapeutics, Inc.'s sale to GSK plc for $58.00 per share, raising concerns about potential violations of shareholder rights and encouraging shareholders to understand their options.
- Merger Transaction Review: The merger between Contango ORE, Inc. and Dolly Varden Silver Corporation will result in Contango shareholders owning approximately 50% of the combined entity, prompting Halper Sadeh LLC to assess whether this transaction serves the best interests of shareholders.
- Shareholder Equity Protection: Tamboran Resources Corporation's merger with Falcon Oil & Gas Ltd. will allow Tamboran shareholders to hold 73.2% of the combined company, with Halper Sadeh LLC urging shareholders to be aware of potential equity losses.
- Legal Support Services: Amicus Therapeutics, Inc. is being sold to BioMarin Pharmaceutical Inc. for $14.50 per share, and Halper Sadeh LLC offers no-cost legal consultations to assist shareholders in protecting their rights.
See More
Monteverde Law Firm Investigates RAPT and Others for Shareholder Recovery
- Shareholder Recovery Investigation: Monteverde & Associates is investigating RAPT Therapeutics, Inc.'s sale to GSK plc, with RAPT shareholders expected to receive $58.00 per share in cash, which could significantly enhance shareholder returns and bolster investor confidence.
- Amicus Transaction Update: In the proposed sale of Amicus Therapeutics, Inc. to BioMarin Pharmaceutical Inc., Amicus shareholders are anticipated to receive $14.50 per share in cash, with a shareholder vote scheduled for March 3, 2026, potentially impacting the company's future market performance.
- Merger Voting Arrangement: Tamboran Resources Corporation's merger with Falcon Oil & Gas Ltd. will result in Tamboran shareholders owning 73.2% of the combined entity, with a shareholder vote set for March 4, 2026, indicating the company's strategic positioning in industry consolidation.
- Contango Merger Details: The merger between Contango Ore, Inc. and Dolly Varden Silver Corporation will allow Contango shareholders to own 50% of the combined company, with a shareholder vote scheduled for March 17, 2026, which may present new growth opportunities for shareholders.
See More
Contango ORE Closes $50 Million Stock Offering
- Successful Stock Offering: Contango ORE has closed its underwritten offering of 1,678,206 shares at $24.96 each, attracting two institutional investors and generating approximately $50 million in gross proceeds, significantly strengthening the company's capital base.
- Clear Use of Proceeds: The company intends to allocate about $45 million for repurchasing gold hedge contracts and $700,000 for purchasing gold put contracts for downside protection, a strategy that will help mitigate the impact of market volatility on its financials.
- Strong Underwriting Team: Canaccord Genuity acted as the Sole Bookrunner for the offering, with Cantor, National Bank of Canada Capital Markets, and ATB Cormark Capital Markets serving as Co-Managers, reflecting strong market confidence and support for Contango.
- Effective Registration Statement: The offering was made under an effective shelf registration statement on Form S-3 declared effective on November 27, 2024, ensuring compliance and transparency, which is likely to enhance investor confidence in the company's future prospects.
See More
Contango ORE to Host Financing Conference Call
- Financing Conference Call: Contango ORE will host a conference call on February 12, 2026, to discuss recent financing aimed at reducing the company's hedge book, which is expected to enhance financial flexibility.
- Project Investment Background: Contango holds a 30% interest in the Peak Gold project in Alaska, covering approximately 675,000 acres, which is anticipated to drive future mineral development and resource assessment.
- Mining Risk Advisory: The company highlighted various risks associated with exploration and development in the mining industry, including geological uncertainties and volatility in natural resource prices, which could impact future production and costs.
- Forward-Looking Statements: Contango emphasized that its forward-looking statements are based on current expectations and estimates, urging investors to exercise caution as actual results may differ due to various factors.
See More
Contango ORE Prices Stock Offering to Raise $50M
- Stock Offering Pricing: Contango ORE has priced an underwritten stock offering at $24.96 per share, selling 1,678,206 shares to two institutional investors, alongside 325,000 pre-funded warrants at $24.95 each, which is expected to raise approximately $50 million in gross proceeds, indicating strong market confidence in the company's stock.
- Use of Proceeds: The company plans to allocate around $45 million of the net proceeds to buy back gold hedge contracts and approximately $700,000 for purchasing gold put contracts for downside protection, a strategy aimed at enhancing financial stability and mitigating market volatility risks.
- Closing Timeline: The offering is expected to close around February 12, 2026, subject to standard closing conditions, demonstrating the company's active engagement in capital markets and confidence in future growth prospects.
- Market Reaction: Following the announcement, CTGO shares rose 2.9% in premarket trading to $28.0, reflecting investor optimism regarding the company's growth potential.
See More
Contango Ore Named Among Top Gold Stocks by Analysts
- Significant Project Progress: Contango Ore has made substantial advancements in its underground drilling program at the Lucky Shot project in Alaska, with initial results confirming the continuity of the historically mined Lucky Shot vein, which is expected to enhance understanding of other veins and strengthen the company's competitive position in the gold market.
- Successful Financing: On February 12, the company completed an underwritten offering of 1.67 million shares, raising $50 million in gross proceeds, with plans to allocate approximately $45 million for buying back gold hedge contracts and $700,000 for purchasing gold put contracts, thereby enhancing financial flexibility.
- Future Planning: Contango Ore aims to deliver a feasibility study for the Lucky Shot project in H1 2027, further validating the geological model and advancing the commercialization process, demonstrating the company's confidence in future development.
- Strategic Partnerships: Contango Ore holds a 30% interest in the Peak Gold Joint Venture, which is expected to commence production in 2024, indicating the company's potential and strategic positioning in Alaska's mining development.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating RAPT Therapeutics, Inc.'s sale to GSK plc for $58.00 per share, raising concerns about potential violations of shareholder rights and encouraging shareholders to understand their options.
- Merger Transaction Review: The merger between Contango ORE, Inc. and Dolly Varden Silver Corporation will result in Contango shareholders owning approximately 50% of the combined entity, prompting Halper Sadeh LLC to assess whether this transaction serves the best interests of shareholders.
- Shareholder Equity Protection: Tamboran Resources Corporation's merger with Falcon Oil & Gas Ltd. will allow Tamboran shareholders to hold 73.2% of the combined company, with Halper Sadeh LLC urging shareholders to be aware of potential equity losses.
- Legal Support Services: Amicus Therapeutics, Inc. is being sold to BioMarin Pharmaceutical Inc. for $14.50 per share, and Halper Sadeh LLC offers no-cost legal consultations to assist shareholders in protecting their rights.
See More
Monteverde Law Firm Investigates RAPT and Others for Shareholder Recovery
- Shareholder Recovery Investigation: Monteverde & Associates is investigating RAPT Therapeutics, Inc.'s sale to GSK plc, with RAPT shareholders expected to receive $58.00 per share in cash, which could significantly enhance shareholder returns and bolster investor confidence.
- Amicus Transaction Update: In the proposed sale of Amicus Therapeutics, Inc. to BioMarin Pharmaceutical Inc., Amicus shareholders are anticipated to receive $14.50 per share in cash, with a shareholder vote scheduled for March 3, 2026, potentially impacting the company's future market performance.
- Merger Voting Arrangement: Tamboran Resources Corporation's merger with Falcon Oil & Gas Ltd. will result in Tamboran shareholders owning 73.2% of the combined entity, with a shareholder vote set for March 4, 2026, indicating the company's strategic positioning in industry consolidation.
- Contango Merger Details: The merger between Contango Ore, Inc. and Dolly Varden Silver Corporation will allow Contango shareholders to own 50% of the combined company, with a shareholder vote scheduled for March 17, 2026, which may present new growth opportunities for shareholders.
See More
Contango ORE Closes $50 Million Stock Offering
- Successful Stock Offering: Contango ORE has closed its underwritten offering of 1,678,206 shares at $24.96 each, attracting two institutional investors and generating approximately $50 million in gross proceeds, significantly strengthening the company's capital base.
- Clear Use of Proceeds: The company intends to allocate about $45 million for repurchasing gold hedge contracts and $700,000 for purchasing gold put contracts for downside protection, a strategy that will help mitigate the impact of market volatility on its financials.
- Strong Underwriting Team: Canaccord Genuity acted as the Sole Bookrunner for the offering, with Cantor, National Bank of Canada Capital Markets, and ATB Cormark Capital Markets serving as Co-Managers, reflecting strong market confidence and support for Contango.
- Effective Registration Statement: The offering was made under an effective shelf registration statement on Form S-3 declared effective on November 27, 2024, ensuring compliance and transparency, which is likely to enhance investor confidence in the company's future prospects.
See More
Contango ORE to Host Financing Conference Call
- Financing Conference Call: Contango ORE will host a conference call on February 12, 2026, to discuss recent financing aimed at reducing the company's hedge book, which is expected to enhance financial flexibility.
- Project Investment Background: Contango holds a 30% interest in the Peak Gold project in Alaska, covering approximately 675,000 acres, which is anticipated to drive future mineral development and resource assessment.
- Mining Risk Advisory: The company highlighted various risks associated with exploration and development in the mining industry, including geological uncertainties and volatility in natural resource prices, which could impact future production and costs.
- Forward-Looking Statements: Contango emphasized that its forward-looking statements are based on current expectations and estimates, urging investors to exercise caution as actual results may differ due to various factors.
See More
Contango ORE Prices Stock Offering to Raise $50M
- Stock Offering Pricing: Contango ORE has priced an underwritten stock offering at $24.96 per share, selling 1,678,206 shares to two institutional investors, alongside 325,000 pre-funded warrants at $24.95 each, which is expected to raise approximately $50 million in gross proceeds, indicating strong market confidence in the company's stock.
- Use of Proceeds: The company plans to allocate around $45 million of the net proceeds to buy back gold hedge contracts and approximately $700,000 for purchasing gold put contracts for downside protection, a strategy aimed at enhancing financial stability and mitigating market volatility risks.
- Closing Timeline: The offering is expected to close around February 12, 2026, subject to standard closing conditions, demonstrating the company's active engagement in capital markets and confidence in future growth prospects.
- Market Reaction: Following the announcement, CTGO shares rose 2.9% in premarket trading to $28.0, reflecting investor optimism regarding the company's growth potential.
See More
